Efficacy and Safety of Fluoxetine in Children and Adolescents with Depression:A Meta-analysis

VernacularTitle:氟西汀治疗儿童青少年抑郁症疗效和安全性的Meta分析
Author: Sisi REN ¹ ; Wei XU ; Hua MING
Author Information

1. 重庆市第九人民医院医院感染管理科
Keywords: Fluoxetine; Depression; Meta-analysis
From: Herald of Medicine 2018;37(2):239-243
CountryChina
Language:Chinese
Abstract: Objective To evaluate efficacy and safety of fluoxetine in comparison with placebo in children and adolescents with depression. Methods Randomized controlled trials (RCTs) on fluoxetine were searched in CBM,Wangfang, VIP,CNKI,PubMed,EMbase,Ovide and Cochrane Library from inception to October 2016 by computer.The pooled mean difference and relative risk were assessed by Meta analysis with RevMan 5.0 software. Results A total of 8 RCTs were included for the final analysis.Curative effect analysis showed:in Children's Global Assessment Scale [MD= 3.91,95％CI(1.66,6.16),P= 0.0007] and Children's Depression Inventory [MD = -1.98,95％CI(-3.40,-0.57),P = 0.006],fluoxetine exerted a good effect in treating children's depression.Fluoxetine was equivalent to placebo in safety. Conclusion This study supports the conclusion that the benefits of fluoxetine in treating children and adolescents with depression are greater than the potential risk.